Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
6.19 0.34(5.81%) Jul 23, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 1,995   1,989   1,989   1,989  
Cost of Revenue -   -   -   -  
Gross Profit 1,995   1,989   1,989   1,989  
Operating Expenses
Research Development7,552  6,883  6,957  7,674  
Selling General and Administrative3,417  2,698  2,807  2,889  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (8,974) (7,592) (7,775) (8,574)
Income from Continuing Operations
Total Other Income/Expenses Net(5,052)1,038  863  1,152  
Earnings Before Interest And Taxes(14,026)(6,554)(6,912)(7,422)
Interest Expense547  623  695  768  
Income Before Tax(14,573)(7,177)(7,607)(8,190)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(14,573)(7,177)(7,607)(8,190)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (14,573) (7,177) (7,607) (8,190)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (14,573) (7,177) (7,607) (8,190)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.